Suppr超能文献

参与抗真菌前药棘白菌素B的生物合成基因簇的阐明及其在工程化厚壁曲霉中的高效生产。

Clarification of the biosynthetic gene cluster involved in the antifungal prodrug echinocandin B and its robust production in engineered Aspergillus pachycristatus.

作者信息

Jiang Kaili, Luo Pan, Wang Xinxin, Song Ping, Chen Jingjing, Lu Ling

机构信息

Department of Clinical Laboratory, Nanjing Drum Tower Hospital, College of Life Science, Nanjing Normal University, Nanjing, Jiangsu, China.

School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, China.

出版信息

Microbiol Res. 2025 Apr;293:128069. doi: 10.1016/j.micres.2025.128069. Epub 2025 Jan 16.

Abstract

Echinocandin antifungals exhibit high efficacy against drug-resistant strains due to their unique mechanism of action. The production of their semi-synthetic precursors relies solely on microbial metabolism, leading to elevated production costs. Anidulafungin, an excellent echinocandin drug, is derived from echinocandin B (ECB), which is industrially produced by Aspergillus pachycristatus. However, the genes involved in the actual ECB biosynthesis remain unclear, which hinders yield improvements through engineered strains. This study systematically investigated the putative ECB biosynthetic gene cluster using genomic and transcriptomic profiling combined with gene editing. Among the 18 putative genes previously reported, only a 13-gene cluster (ecdA, ecdG-J, htyA-F) was found to be actively involved in ECB biosynthesis, while the remaining 5 genes (ecdB-F) were non-essential and functioned independently. Notably, we identified that htyC and htyD were involved in L-homotyrosine biosynthesis, while HtyF catalyzed the C4 hydroxylation of 3S-hydroxyl-L-homotyrosine. Most importantly, EcdJ was identified as a crucial global transcriptional activator regulating the ECB gene cluster. Deletion of ecdJ silenced all related genes and abolished ECB production. Accordingly, overexpressing ecdJ alone or combining ecdA and htyF together significantly enhanced ECB yield. Under optimized liquid fermentation conditions, ECB production in the OEecdJ strain achieved 841 ± 23.11 mg/L. Solid-state fermentation further enhanced the ECB yield to 1.5 g/L, which is 7.7-fold higher than that of the wild-type strain under initial liquid fermentation conditions. This study has thoroughly elucidated the functions of key genes involved in the ECB biosynthesis and provided effective strategies for enhancing antifungal prodrug-ECB production, achieving the highest ECB production in an engineering A. pachycristatus strain.

摘要

棘白菌素类抗真菌药物因其独特的作用机制而对耐药菌株表现出高效性。其半合成前体的生产完全依赖于微生物代谢,导致生产成本升高。阿尼芬净是一种优秀的棘白菌素类药物,它由棘白菌素B(ECB)衍生而来,而ECB是由厚壁曲霉工业生产的。然而,实际参与ECB生物合成的基因仍不清楚,这阻碍了通过工程菌株提高产量。本研究结合基因组和转录组分析以及基因编辑,系统地研究了假定的ECB生物合成基因簇。在先前报道的18个假定基因中,仅发现一个由13个基因组成的簇(ecdA、ecdG-J、htyA-F)积极参与ECB生物合成,而其余5个基因(ecdB-F)并非必需且独立发挥作用。值得注意的是,我们确定htyC和htyD参与L-高酪氨酸的生物合成,而HtyF催化3S-羟基-L-高酪氨酸的C4羟基化反应。最重要的是,EcdJ被确定为调控ECB基因簇的关键全局转录激活因子。删除ecdJ会使所有相关基因沉默并消除ECB的产生。因此,单独过表达ecdJ或同时过表达ecdA和htyF可显著提高ECB产量。在优化的液体发酵条件下,OEecdJ菌株中的ECB产量达到841±23.11mg/L。固态发酵进一步将ECB产量提高到1.5g/L,这比初始液体发酵条件下野生型菌株的产量高7.7倍。本研究全面阐明了参与ECB生物合成的关键基因的功能,并为提高抗真菌前体药物ECB的产量提供了有效策略,在工程化的厚壁曲霉菌株中实现了最高的ECB产量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验